Scarica l'app Stockscreener
3.4247
1.01%
-0.0353
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ESPR Giù?
Forum
Previsione
Frazionamento azionario
Esperion Therapeutics Inc Borsa (ESPR) Ultime notizie
New hires at Esperion receive 40,200 restricted stock units as hiring incentive - Stock Titan
Market Trends: How does Esperion Therapeutics Inc. score in quality rankings2025 Key Highlights & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
What is the next catalyst for Esperion Therapeutics IncWeekly Investment Report & Expert Curated Trade Setups - baoquankhu1.vn
Weekly Trades: How does Esperion Therapeutics Inc. score in quality rankingsMarket Risk Report & Daily Oversold Stock Bounce Ideas - baoquankhu1.vn
Esperion Therapeutics Inc. (ESPR) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Zacks Research Issues Optimistic Forecast for ESPR Earnings - MarketBeat
Zacks Research Analysts Reduce Earnings Estimates for ESPR - MarketBeat
Esperion Therapeutics (NASDAQ:ESPR) Raised to "Buy" at Wall Street Zen - MarketBeat
How The New Price Target Is Shaping The Story For Esperion Therapeutics (ESPR) - Yahoo Finance
3,000,000 Shares in Esperion Therapeutics, Inc. $ESPR Bought by AIGH Capital Management LLC - MarketBeat
Esperion Therapeutics (NASDAQ:ESPR) Downgraded to Hold Rating by Wall Street Zen - MarketBeat
Analyst Downgrade: What are Esperion Therapeutics Incs technical support levelsInflation Watch & Free Reliable Trade Execution Plans - baoquankhu1.vn
Esperion Therapeutics general counsel sells $4.9k in stock By Investing.com - Investing.com Australia
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Esperion Therapeutics general counsel sells $4.9k in stock - Investing.com
Esperion Therapeutics warns of winter cholesterol risk - Traders Union
Is Esperion Therapeutics Inc. stock a falling knife or bargain buyJuly 2025 Update & Stepwise Trade Signal Guides - bollywoodhelpline.com
Winners Losers: Is Esperion Therapeutics Inc a defensive stockMarket Sentiment Report & Entry and Exit Point Strategies - baoquankhu1.vn
Esperion Therapeutics (NASDAQ:ESPR) Shares Gap DownShould You Sell? - MarketBeat
What is HC Wainwright's Estimate for ESPR FY2025 Earnings? - MarketBeat
Esperion Seeks Acquisitions - marketscreener.com
How does Esperion Therapeutics Inc score in quality rankingsDip Buying & Safe Entry Trade Signal Reports - baoquankhu1.vn
Highs Report: What is Esperion Therapeutics Incs TAM Total Addressable MarketJuly 2025 Sector Moves & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
HC Wainwright Issues Optimistic Estimate for ESPR Earnings - MarketBeat
Esperion Therapeutics Faces Financial Challenges Amid Market Uncertainty - StocksToTrade
Esperion Therapeutics (NASDAQ:ESPR) Shares Down 6.3%Here's Why - MarketBeat
Esperion Projects FY2025 U.S. Net Product Sales Growth Of 35% To 38%; Stock Up - Nasdaq
Esperion Reports $156-$160 Million in 2025 Sales, Unveils Vision 2040 Strategy - Intellectia AI
Esperion Reports Significant Growth in Preliminary 2025 Financial Results and Unveils Vision 2040 Growth Strategy - Quiver Quantitative
Esperion reports $156 to $160 million in preliminary full-year 2025 U.S. net product sales - marketscreener.com
Esperion Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Cholesterol drug maker lays 2040 plan as new pills target 60% LDL drop - Stock Titan
Why Esperion Therapeutics Inc stock attracts global investorsMarket Movers & Community Verified Trade Signals - moha.gov.vn
Esperion Therapeutics Stock Hits Near 1-Year High As Wall Street Sees Strong Risk-Reward Play On Demand For Cholesterol Drug - MSN
Can Esperion Therapeutics Inc. stock sustain institutional interest2025 Market Sentiment & AI Driven Price Predictions - Улправда
Will Esperion Therapeutics Inc. (0ET) stock beat growth indexesQuarterly Performance Summary & Trade Opportunity Analysis - ulpravda.ru
Is Esperion Therapeutics Inc. (0ET) stock considered safe havenJuly 2025 Chart Watch & Verified Momentum Stock Watchlist - ulpravda.ru
Merger Talk: Is Esperion Therapeutics Inc. (0ET) stock considered safe haven2025 Winners & Losers & Reliable Momentum Entry Alerts - Улправда
Esperion Therapeutics (NASDAQ:ESPR) Sets New 12-Month HighHere's Why - MarketBeat
Esperion Therapeutics gets Untitled Letter from FDA over Nexlizet ad - Medical Marketing and Media
How Esperion Therapeutics Inc. stock performs in rising dollar environmentQuarterly Profit Report & Technical Buy Zone Confirmations - Улправда
Free Technical Research Reports on Biotech Stocks -- Epizyme, Esperion Therapeutics, Exelixis, and Grifols - ADVFN
Will Esperion Therapeutics Inc. (0ET) stock outperform value peersVolume Profile Analysis & Double Digit Returns - Улправда
Esperion Sets Its Sights on New Areas While Maintaining Commitment to Cardiovascular Health - MedCity News
Esperion Therapeutics chief commercial officer sells $277 in stock - MSN
Esperion to Participate in Upcoming 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
What analysts say about Esperion Therapeutics Inc stockMarket Volatility Update & Rapid Wealth Accumulation - earlytimes.in
Why Is Esperion Therapeutics Stock Sinking Premarket Today? - MSN
Esperion Therapeutics (NASDAQ:ESPR) Upgraded by Wall Street Zen to "Buy" Rating - MarketBeat
Esperion Therapeutics (NASDAQ:ESPR) Shares Gap UpWhat's Next? - MarketBeat
Is Esperion Therapeutics Inc a good long term investmentGlobal Trade Effects & Free Rapid Wealth Building - earlytimes.in
Esperion Therapeutics (NASDAQ:ESPR) Shares Down 4.8%Time to Sell? - MarketBeat
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
0.63%
10.18%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):